Revised Blood Pressure Recommendations for Type 2 Diabetes

Importance of Target Blood Pressure

Researchers from Jiao Tong University advocate that individuals with type 2 diabetes should strive for a blood pressure target of 120 mm Hg to effectively lower their risk of major cardiovascular events. A substantial clinical trial conducted in China indicates that the existing blood pressure guidelines for this demographic may require reevaluation.

Study Overview

The findings, published last month in the New England Journal of Medicine, stem from a collaboration of medical professionals across the People’s Republic of China and experts in Shanghai. The study aimed to assess whether current blood pressure guidelines adequately address the needs of individuals with type 2 diabetes, particularly considering the condition’s significant impact on cardiovascular health.

Understanding Hypertension Risks

Current Guidelines

Historically, the recommended blood pressure threshold for individuals with type 2 diabetes has been set at a systolic level below 140 mm Hg, deemed the critical limit for hypertension. Hypertension, characterized by elevated blood pressure, increases the risk of cardiovascular events, including strokes and heart attacks.

Findings from the Study

The researchers assert that maintaining blood pressure below this threshold may not sufficiently mitigate risks for type 2 diabetics. After conducting a large randomized controlled trial with over 12,000 participants, they suggest that aiming for a blood pressure of 120 mm Hg or lower may significantly reduce cardiovascular risk in this population, particularly in Asia.

Evaluating Cardiovascular Risks

The Impact of Multiple Risk Factors

It is well-established that managing blood pressure effectively reduces the likelihood of cardiovascular incidents. However, the complexity increases when multiple risk factors coexist, such as stress, obesity, smoking, and genetic predisposition to hypertension. The presence of type 2 diabetes introduces additional challenges, necessitating comprehensive risk management strategies.

Rethinking Blood Pressure Targets

The Shanghai researchers hypothesized that adopting a lower target of 120 mm Hg could lead to a decrease in cardiovascular events among type 2 diabetics. Their experiment compared outcomes between two groups: one adhering to standard hypertension therapy and another aiming for the lower target through more rigorous treatment.

Clinical Trial Methodology

Study Design

In this controlled trial, participants aged over 50 with systolic blood pressure readings between 130 mm Hg and 180 mm Hg were recruited from 145 hospitals. The cohort included individuals at high risk for cardiovascular issues, including those with chronic kidney disease or a history of cardiovascular disease.

Group Assignments

Participants were randomly assigned to one of two groups: one receiving standard treatment aimed at achieving blood pressure below 140 mm Hg and the other targeting a systolic pressure below 120 mm Hg. The groups were matched for age, sex, education, medical history, and baseline health metrics.

Study Outcomes

Long-Term Results

Over five years, the study revealed significant findings. The intensive blood pressure control group achieved an average systolic blood pressure of 118 mm Hg, while the standard treatment group reached 133 mm Hg. Notably, participants in the lower target group experienced a 21% reduced likelihood of primary cardiovascular outcomes compared to those in the standard treatment group.

Adverse Events and Limitations

The incidence of adverse events was similar between both groups, indicating that the intensive management approach did not pose additional risks. However, the study faced limitations, including participant dropout and reliance on self-reported data during the pandemic. Additionally, the trial primarily focused on systolic blood pressure, leaving diastolic responses unexamined.

Implications for Future Care

Cultural Considerations

The findings are particularly relevant for East Asian populations, who are predisposed to higher risks of type 2 diabetes and hypertension. It is essential to explore whether similar recommendations can be applied to diverse ethnic groups before establishing new care standards.

Conclusion

The study’s results underscore the potential benefits of lowering blood pressure targets for individuals with type 2 diabetes, particularly in preventing strokes and other cardiovascular complications. As the research suggests, adjusting the target to below 120 mm Hg may significantly improve health outcomes, highlighting the need for reevaluation of current clinical practices.

References

Bi Y, Li M, Liu Y, et al. Intensive Blood-Pressure Control in Patients with Type 2 Diabetes. New England Journal of Medicine. 2025;392(12):1155-1167. doi:10.1056/NEJMoa2412006